Retraction Notice To: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing P53-Mediated Mir-205-5p Expression.

Hong-Yu Ma,Yan Li,Hui-Zi Yin,Hang Yin,Yuan-Yuan Qu,Qing-Yong Xu

DOI: https://doi.org/10.1016/j.omtn.2020.09.025

IF: 10.183

2020-01-01

Molecular Therapy — Nucleic Acids

Abstract:[This retracts the article DOI: 10.1016/j.omtn.2020.09.025.].

What problem does this paper attempt to address?

Retracted: mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9

BioMed Research International

DOI: https://doi.org/10.1155/2024/9803876

2024-01-09

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2021/6622342.].

biotechnology & applied microbiology,medicine, research & experimental
Retraction Notice To: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells

Yunhao Chen,Hui Zhao,Haibo Li,Xiao Feng,Hui Tang,Chunhui Qiu,Jianwen Zhang,Binsheng Fu

DOI: https://doi.org/10.1016/j.omtn.2019.10.035

IF: 10.183

2019-01-01

Molecular Therapy — Nucleic Acids

Abstract:[This retracts the article DOI: 10.1016/j.omtn.2019.10.035.].
MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Retraction]

Rui-Peng Zheng,Dong-Kai Ma,Zhuo Li,Hai-Feng Zhang

DOI: https://doi.org/10.2147/cmar.s440059

2023-09-01

Cancer Management and Research

Abstract:[This retracts the article DOI: 10.2147/CMAR.S257598.].

oncology
Retraction Notice to: circIFT80 Functions as a ceRNA of miR-1236-3p to Promote Colorectal Cancer Progression

Wenming Feng,Hui Gong,Yongchun Wang,Guoliang Zhu,Tao Xue,Yao Wang,Ge Cui

DOI: https://doi.org/10.1016/j.omtn.2024.102214

2024-05-18

Abstract:[This retracts the article DOI: 10.1016/j.omtn.2019.08.024.].
Retracted: miR-339-5p Inhibits Autophagy to Reduce the Resistance of Laryngeal Carcinoma on Cisplatin via Targeting TAK1

BioMed Research International

DOI: https://doi.org/10.1155/2024/9834839

2024-03-21

BioMed Research International

Abstract:This article has been retracted by Hindawi following an investigation undertaken by the publisher [1]. This investigation has uncovered evidence of one or more of the following indicators of systematic manipulation of the publication process: (1) Discrepancies in scope (2) Discrepancies in the description of the research reported (3) Discrepancies between the availability of data and the research described (4) Inappropriate citations (5) Incoherent, meaningless and/or irrelevant content included in the article (6) Manipulated or compromised peer review

biotechnology & applied microbiology,medicine, research & experimental
Retraction: Oxymatrine Synergistically Potentiates the Antitumor Effects of Cisplatin in Human Gastric Cancer Cells

Yan Liu,Lei Qin,Tingting Bi,Wei Dai,Wei Liu,Quangen Gao,Genhai Shen

DOI: https://doi.org/10.7150/jca.61392

IF: 3.9

2021-01-01

Journal of Cancer

Abstract:[This retracts the article DOI: 10.7150/jca.28532.].

oncology
Retracted: miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression

Computational Intelligence And Neuroscience

DOI: https://doi.org/10.1155/2023/9831724

2023-12-13

Abstract:[This retracts the article DOI: 10.1155/2022/7179733.].
Retraction Notice To: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 Mrna Translation in an M6a-Dependent Manner

Xiangxiang Liu,Jian Qin,Tianyi Gao,Chenmeng Li,Bangshun He,Bei Pan,Xueni Xu,Xiaoxiang Chen,Kaixuan Zeng,Mu Xu,Chengbin Zhu,Yuqin Pan,Huiling Sun,Li Sun,Tao Xu,Shukui Wang

DOI: https://doi.org/10.1016/j.omtn.2022.04.027

2022-01-01

Abstract:[This retracts the article DOI: 10.1016/j.omtn.2020.09.036.].
Retraction: miR-181a-5p Promotes Proliferation and Invasion and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A)

Oncology Research Editorial Office

DOI: https://doi.org/10.32604/or.2024.056126

2024-08-23

Abstract:[This retracts the article DOI: 10.3727/096504017X14982569377511.].
Retraction: Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52)

Oncology Research Editorial Office

DOI: https://doi.org/10.32604/or.2024.056119

2024-08-23

Abstract:[This retracts the article DOI: 10.3727/096504016X14772342320617.].
Erratum: Transcriptional Downregulation of Mir-4306 Serves As a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.

Zitong Zhao,Lin Li,Peina Du,Liying Ma,Weimin Zhang,Leilei Zheng,Bo Lan,Bailin Zhang,Fei Ma,Bo Xu,Qimin Zhan,Yongmei Song

DOI: https://doi.org/10.7150/thno.82636

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30701.].
Retraction Note: Nuclear Factor of Activated T Cells 5 Maintained by Hotair Suppression of Mir-568 Upregulates S100 Calcium Binding Protein A4 to Promote Breast Cancer Metastasis

Jun-Tang Li,Li-Feng Wang,Ya-Li Zhao,Tao Yang,Wei Li,Jing Zhao,Feng Yu,Lei Wang,Yan-Ling Meng,Ning-Ning Liu,Xiao-Shan Zhu,Chun-Fang Gao,Lin-Tao Jia,An-Gang Yang

DOI: https://doi.org/10.1186/s13058-014-0454-2

2014-01-01

Breast Cancer Research

Abstract:The authors are retracting this article [1] after an investigation by the Ethics Committee of the Fourth Military Medical University (Xi'an, Shaanxi, China) of the following concerns that had been raised with respect to two of the figures.
Retraction to "MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB"

Shufang Li,Yuping Feng,Yuxia Huang,Yu Liu,Yanxi Wang,Yan Liang,Hui Zeng,Hong Qu,Ling Wei

DOI: https://doi.org/10.1515/biol-2023-0002

2024-08-26

Abstract:[This retracts the article DOI: 10.1515/biol-2020-0040.].
[Retracted] Tumor suppressor miR‐613 induces cisplatin sensitivity in non‐small cell lung cancer cells by targeting GJA1

Jianhua Luo,Yan Jin,Mengyuan Li,Liyang Dong

DOI: https://doi.org/10.3892/mmr.2024.13291

IF: 3.423

2024-09-19

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the colony formation assay data shown in Fig. 2F, the tumor images in Fig. 3A, the "NC" experiment for the Ki67 immunohistochemical staining experiment shown in Fig. 3E and the migration assay data in Fig. 4D were strikingly similar to data appearing in different form in other papers by different authors at different research institutes that had either already been published, or were under consideration for publication at around the same time. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 23: 385, 2021; DOI: 10.3892/mmr.2021.12024]

oncology,medicine, research & experimental
Retraction: Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway. Li-Li Wang, Wei-Wei Huang, Jing Huang, Rong-Fang Huang, Na-Ni Li, Yi Hong, Mu-Lan Chen, Fan Wu, Jian Liu, Kaohsiung J Med Sci. 2020; 36(8): 581-591 (https://doi.org/10.1002/kjm2.12212)

DOI: https://doi.org/10.1002/kjm2.12790

Abstract:The above article, published online on 20 April 2020, and a corresponding corrigendum for Figure 7, published on 14 March 2022, in Wiley Online Library (wileyonlinelibrary.com), have been retracted by agreement between the authors, the journal Editor-in-Chief, Wan-Long Chuang, and John Wiley and Sons Ltd. The retraction has been agreed due to a high degree of duplication and similarity of the images presented in this manuscript. Original data for this manuscript is no longer available, Accordingly, the conclusions of this manuscript are not considered reliable.
[Retracted] Human HLA‐F adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer

Chen Li,Zhenfan Wang,Ninghan Feng,Jian Dong,Xiaoyan Deng,Yin Yue,Yuehong Guo,Jianquan Hou

DOI: https://doi.org/10.3892/mmr.2024.13187

IF: 3.423

2024-02-29

Molecular Medicine Reports

Abstract:Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the cellular morphological data in Fig. 1C, the immunofluorescence data shown in Fig. 1E, and certain of the scratch‐wound assay data shown in Fig. 2A were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had already been published. Owing to the fact that the contentious data in the above article had already been published prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 18: 308‐314, 2018; DOI: 10.3892/mmr.2018.9005]

oncology,medicine, research & experimental
Correction: Huang et al. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer. Cells 2021, 10, 2524

Wei-Chieh Huang,Hsiang-Cheng Chi,Shiao-Lin Tung,Po-Ming Chen,Ya-Chi Shih,Yi-Ching Huang,Pei-Yi Chu

DOI: https://doi.org/10.3390/cells13221830

IF: 6

2024-11-07

Cells

Abstract:Cells, Vol. 13, Pages 1830: Correction: Huang et al. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer. Cells 2021, 10, 2524 Cells doi: 10.3390/cells13221830 Authors: Wei-Chieh Huang Hsiang-Cheng Chi Shiao-Lin Tung Po-Ming Chen Ya-Chi Shih Yi-Ching Huang Pei-Yi Chu In the original publication [...]

cell biology
Retracted: Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway

BioMed Research International

DOI: https://doi.org/10.1155/2024/9825952

2024-01-13

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2021/2342784.].

biotechnology & applied microbiology,medicine, research & experimental
Retraction Statement: Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma

DOI: https://doi.org/10.1002/1878-0261.13451

Abstract:The above article, published online on January 10, 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor in Chief, Kevin Ryan and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications between this and two previously published studies [1, 2] by unrelated groups of authors. Thus, the editors consider the conclusions of this manuscript substantially compromised. [1] MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression. DOI: 10.18632/oncotarget.11877 Oncotarget. 2016 Oct 11; 7(41): 66922-66934. [2] ShRNA knock-down of CXCR7 inhibits tumour invasion and metastasis in hepatocellular carcinoma after transcatheter arterial chemoembolization. DOI: 10.1111/jcmm.13119 J Cell Mol Med. 2017 Sep;21(9):1989-1999. Reference 1 Gao J, Dai C, Yu X, Yin X-B, Zhou F. Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma. Mol Oncol. 2020;14:447-61. https://doi.org/10.1002/1878-0261.12603.
Retraction Notice to: LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM24

Tao Lv,Yichao Jin,Yifeng Miao,Tianqi Xu,Feng Jia,Haizhong Feng,Xiaohua Zhang

DOI: https://doi.org/10.1016/j.omtn.2024.102323

2024-09-10

Abstract:[This retracts the article DOI: 10.1016/j.omtn.2021.11.012.].

Retraction Notice To: TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing P53-Mediated Mir-205-5p Expression.

Retracted: mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9

Retraction Notice To: LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells

MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Retraction]

Retraction Notice to: circIFT80 Functions as a ceRNA of miR-1236-3p to Promote Colorectal Cancer Progression

Retracted: miR-339-5p Inhibits Autophagy to Reduce the Resistance of Laryngeal Carcinoma on Cisplatin via Targeting TAK1

Retraction: Oxymatrine Synergistically Potentiates the Antitumor Effects of Cisplatin in Human Gastric Cancer Cells

Retracted: miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression

Retraction Notice To: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 Mrna Translation in an M6a-Dependent Manner

Retraction: miR-181a-5p Promotes Proliferation and Invasion and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A)

Retraction: Downregulation of MicroRNA-449 Promotes Migration and Invasion of Breast Cancer Cells by Targeting Tumor Protein D52 (TPD52)

Erratum: Transcriptional Downregulation of Mir-4306 Serves As a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.

Retraction Note: Nuclear Factor of Activated T Cells 5 Maintained by Hotair Suppression of Mir-568 Upregulates S100 Calcium Binding Protein A4 to Promote Breast Cancer Metastasis

Retraction to "MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB"

[Retracted] Tumor suppressor miR‐613 induces cisplatin sensitivity in non‐small cell lung cancer cells by targeting GJA1

[Retracted] Human HLA‐F adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer

Correction: Huang et al. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer. Cells 2021, 10, 2524

Retracted: Upregulating hsa-miR-128a Increased the Effects of Pembrolizumab on Laryngeal Cancer Cells via the p53 Pathway

Retraction Statement: Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma

Retraction Notice to: LncRNA PVT1 promotes tumorigenesis of glioblastoma by recruiting COPS5 to deubiquitinate and stabilize TRIM24